EDITORIAL
Published on 16 Jan 2025
Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling
doi 10.3389/fimmu.2024.1548624
- 496 views
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Immune studies of SARS-CoV2 and vaccines using preclinical modeling
Immune studies of SARS-CoV2 and vaccines using preclinical modeling
7,514
Total downloads
25k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 14 Oct 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain
doi 10.3389/fimmu.2024.1440324
- 1,495 views
ORIGINAL RESEARCH
Published on 30 Aug 2024
Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters
doi 10.3389/fimmu.2024.1430928
- 1,231 views
ORIGINAL RESEARCH
Published on 10 Jul 2024
Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
doi 10.3389/fimmu.2024.1428711
- 1,205 views
ORIGINAL RESEARCH
Published on 21 Jun 2024
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency
doi 10.3389/fimmu.2024.1406138
- 3,798 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Jun 2024
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
doi 10.3389/fimmu.2024.1424374
- 1,159 views
- 2 citations
REVIEW
Published on 26 Feb 2024
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
doi 10.3389/fimmu.2024.1345499
- 1,745 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 Feb 2024
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
doi 10.3389/fimmu.2024.1292059
- 1,650 views
- 4 citations
ORIGINAL RESEARCH
Published on 22 Jan 2024
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
doi 10.3389/fimmu.2024.1328905
- 3,738 views
- 16 citations
ORIGINAL RESEARCH
Published on 04 Dec 2023
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
doi 10.3389/fimmu.2023.1291972
- 1,771 views
- 1 citation
